| Name | Agronomics Limited |
|---|---|
| Epic | ANIC |
| Isin | IM00B6QH1J21 |
| Industry | Pharmaceuticals & Biotechnology |
| Latest share price | 3.95p | Net gearing | n/a |
|---|---|---|---|
| Market capitalisation | £39.87 | Debt ratio | n/a |
| Shares in issue | 1,009.41 | Debt-to-equity ratio | n/a |
| P/E ratio | 4.6 | Assets / equity ratio | n/a |
| Total dividends per share | n/a | Price to book value | n/a |
| Dividend yield | n/a | ROCE | n/a |
| Dividend cover | n/a | EPS growth | 139 |
| Earning per share | 2.27 | 52-week high / low | 3.90p / 13.40p |
| Type | Ex-date | Pay-date | Net-dividend |
|---|---|---|---|
| No dividends declared | |||
| Company name | Agronomics Limited |
|---|---|
| Address | Viking House, St Paul's Square, Ramsey ,Isle of Man, IM8 1GB |
| Telephone | |
| Website | http://www.agronomics.im |
| Director | Position |
|---|---|
| Mr Denham Hervey Newall Eke | Finance Director |
| Mrs Marisa Drew | Non-Executive Director |
| Mr James (Jim) Mellon | Executive Chairman |
| Mr Richard Reed | Independent Non-Executive Director |
| Mr David Giampaolo | Independent Non-Executive Director |
| Assets £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Reporting date | 30/06/23 | 30/06/22 | 30/06/21 |
| Intangible asssets and goodwill | n/a | n/a | n/a |
| Investments and other non-current assets | n/a | n/a | n/a |
| Total non-current assets | n/a | n/a | n/a |
| Inventory / work in progress | n/a | n/a | n/a |
| Trade and other receivables | 0.34 | 0.1 | 0.45 |
| Cash and equivalents | 18.09 | 31.46 | 62.44 |
| Other current assets and asset held for resale | 151.77 | 114.84 | 38.77 |
| Total of all assets | 170.2 | 146.4 | 101.65 |
| Liabilities £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Short term liabilities | 1.95 | 2.49 | 1.62 |
| Long term liabilities | n/a | n/a | n/a |
| Other liabilites / pension etc | n/a | n/a | n/a |
| Total of all liabilities | 1.95 | 2.49 | 1.62 |
| Net assets £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Net assets | 168.26 | 143.91 | 100.03 |
| Equity £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Share capital | n/a | n/a | n/a |
| Minority interests | n/a | n/a | n/a |
| Retained earnings | 32.09 | 9.71 | 1.36 |
| Share premium account | 134.48 | 129.86 | 91.28 |
| Total equity | 168.26 | 143.91 | 100.03 |
| Income £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Turnover | n/a | n/a | n/a |
| Operating profit | 21.2 | 8.01 | 0.87 |
| Pre-tax profit | 22.37 | 8.36 | 1.02 |